Skip to content
Subscribe

Case Study Slider TEST

Atelerix was the first Northern Accelerator spin-out, with CEO Dr Mick McLean recruited through the project’s ‘Execs into Business’ programme.


Atelerix Newcastle University

This Durham University spin-out is helping companies discover and develop new age-related treatments faster.


Magnitude Biosciences Durham University

Healthcare experts and collaborators at Sunderland have been awarded funding of almost £50,000 from Northern Accelerator to develop a drug for the pre-clinical proof-of-concept stage over the next eight months


Research to treat rare genetic diseases University of Sunderland

This innovative device could revolutionise the way we diagnose diseases, such as the newly emerged strain of coronavirus, COVID-19.


Pulmo Bio Med Ltd Northumbria University

Professor Kataky’s innovative work with biofilms to control the formation and spread of bacteria will make a real-world impact in the form of smart bandage technology. This can reduce reliance on antibiotics and improve patient outcomes, by reducing the risk of disease and infection when treating wounds.


Professor Ritu Kataky Durham University
Professor Che Connon

Professor Che Connon is a serial academic entrepreneur, spinning out three companies from Newcastle University and bridging the gap between academia and private enterprise.


Professor Che Connon Newcastle University

Growing up in North-Eastern Italy, Martina had a passion for STEM from a very young age.


Dr Martina Miotto Newcastle University
Funded by UK Gov-stacked_0
DCC
Research+England+logo copy

Subscribe to our Mailing List

Privacy policy | Accessibility Statement

© 2026 Northern Accelerator

Linkedin
Designed by Curious12
  • Home
  • About us
  • Case Studies
  • Our Support
  • News
  • Contact Us